Likely culprit in spread of colon cancer identified

April 1, 2014
Likely culprit in spread of colon cancer identified
New research at Washington University School of Medicine in St. Louis and Vanderbilt University Medical Center in Nashville has implicated a poorly understood protein called PLAC8 in the spread of colon cancer. Growing in three dimensional culture, colon cancer cells formed either smooth hollow structures (top) or spiky clumps (bottom). PLAC8 was highly expressed in the spiky clumps, which were shown to form rapidly spreading tumors in mice. Credit: Cunxi Li, M.D., Ph.D.

New research at Washington University School of Medicine in St. Louis and Vanderbilt University Medical Center in Nashville has implicated a poorly understood protein called PLAC8 in the spread of colon cancer.

While elevated PLAC8 levels were known to be associated with , the researchers now have shown that the protein plays an active role in shifting normal cells lining the colon into a state that encourages metastasis.

The work appears April 1 in the Journal of Clinical Investigation.

"We knew levels of this protein are elevated in colon cancer," said co-author Lilianna Solnica-Krezel, PhD, professor and head of the Department of Developmental Biology at Washington University. "Now we've shown what PLAC8 could be doing—causing the cells to transition to a state that allows them to spread.

"This discovery developed from a collaboration between my group studying zebrafish and Robert Coffey's lab looking at human cells, both initially at Vanderbilt," she said. "Since 2010, my group has continued the zebrafish work at Washington University."

Senior author Robert Coffey, MD, the Ingram Professor of Cancer Research at Vanderbilt University, and his group have been developing new methods to grow colon cancer cells in three dimensions, rather than using typical procedures to grow cells in a flat dish.

Coffey's group observed that growing in three dimensions formed either smooth hollow balls or spiky clumps with protrusions extending into the surroundings. Compared to the smooth balls, the spiky clumps were shown to form rapidly spreading tumors in mice. When the researchers compared gene expression between the cells forming smooth balls and those forming spiky clumps, PLAC8 stood out. It was expressed at extremely high levels in the spiky clumps that formed aggressive tumors.

To gain a better understanding of PLAC8, Haiting Ma, PhD, a former graduate student in the Solnica-Krezel and Coffey labs, used a zebrafish model system to investigate the roles of this protein.

"We looked at this protein in zebrafish and saw that it was also expressed in the gut," said Solnica-Krezel. "In normal zebrafish, PLAC8 is present on the inner lining of the gut. We also noticed PLAC8 is heavily expressed in the early embryos of zebrafish."

Ma and his colleagues looked further into the developmental roles of PLAC8 and found that when there is too much of this protein, the zebrafish embryo developed abnormally, with slower cell movements resulting in an abnormal body shape and other developmental defects.

"We realized that these defects were very similar to abnormalities we see when the protein E-cadherin is mutated," Solnica-Krezel said. "E-cadherin is a cell adhesion molecule present on the cell surface, which allows cells to stick to one another. The amount of E-cadherin on the surface is very important for cell movement, with too much or too little being detrimental to mobility."

E-cadherin is also important in maintaining the sheet-like tissue structure called epithelium, which forms the inner lining of many organs, including the gut. Loss of E-cadherin can indicate a process known as epithelial-to-mesenchymal transition, where the cells detach, and the tissue loses its sheet-like nature, making it easier for the cells to migrate.

During early development, these transitions are normal, as cells must migrate to different parts of the developing organism and form new tissues and organs. But in cancer, this transition to more mobile can be the tipping point that causes them to break away from a tumor and invade neighboring tissues.

"Scientists know a lot about E-cadherin," Solnica-Krezel said. "But this is the first link between PLAC8 and E-cadherin. Nobody knew that PLAC8 could regulate it. Too much PLAC8 causes E-cadherin levels to go down, and low E-cadherin is associated with abnormal cell movement."

Moving full circle, first with , then with zebrafish, the researchers returned to human tissues to investigate PLAC8 and associated proteins in colorectal tumors. They demonstrated that many markers of the epithelial-to-mesenchymal transition observed in zebrafish embryos with too much PLAC8 were also present at the edge of a human colon tumor.

Solnica-Krezel speculates PLAC8 could be an interesting target for future work in developing new cancer therapies.

"One could think about finding chemicals that might inhibit PLAC8's activity," she said. "But at present, this finding may have prognostic value. Those tumors expressing PLAC8 at high levels will be the most invasive."

Explore further: Zebrafish help decode link between calcium deficiency and colon cancer

More information: Li C, Ma H, Wang Y, Cao Z, Graves-Deal R, Powell AE, Starchenko A, Ayers GD, Washington MK, Kamath V, Desai K, Gerdes MJ, Solnica-Krezel L, Coffey RJ. Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer. Journal of Clinical Investigation. April 1, 2014.

Related Stories

Zebrafish help decode link between calcium deficiency and colon cancer

December 13, 2013
A tiny, transparent fish embryo and a string of surprises led scientists to a deeper understanding of the perplexing link between low calcium and colon cancer.

When cells are consumed by wanderlust

July 22, 2013
(Medical Xpress)—In experiments on zebrafish, Freiburg researchers have demonstrated that the same proteins that lead to the formation of metastases in humans also cause the cells to migrate during embryonic development. ...

Landmark study describes prostate cancer metastasis switch

April 2, 2013
Prostate cancer doesn't kill in the prostate – it's only once the disease travels to bone, lung, liver, etc. that it turns fatal. Previous studies have shown that loss of the protein E-Cadherin is essential for this metastasis. ...

Dental researchers discover how an oral bacterium can trigger colorectal cancer

August 14, 2013
Researchers from Case Western Reserve University School of Dental Medicine have discovered how a common oral bacterium can contribute to colorectal cancer, a finding that opens promising new research avenues for the development ...

Recommended for you

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.